Literature DB >> 26427116

Effect of Chaihushugan San on expression of the Raf/mitogen-activated protein kinase/extracellular signal-regulated kinase pathway in the hippocampi of perimenopausal rats induced by immobilization stress.

Li Shengqiang, Liang Wenna, Li Yachan, Chen Yunlong, Chen Shujiao, Li Candong.   

Abstract

OBJECTIVE: We wished to study the impact of Chaihushugan San (CSS) on the behavior of perimenopausal rats with liver-Qi stagnation (LQS) and to investigate the effect of CSS on signal transduction of the Raf/mitogen-activated protein kinase (MEK)/ extracellular signal-regulated kinase (ERK) cascade in the hippocampi of rats induced by immobilization.
METHODS: Twenty 52-week-old female rats were divided into two groups by the random number table method: model control group (MCG) and CSS group (CSSG), with 10 rats in each group. Ten-week-old female rats were used as the normal control group (NCG). CSS effects were assessed using rats exposed to immobilization stress by measuring body weight and sucrose consumption, serum hormone levels, and observing performance in the open field test (OFT). Molecular mechanisms were examined by measuring the effect of CSS on expression of Raf1, MEK1/2 and ERK1/2 mRNA in hippocampi using quantitative real-time polymerase chain reaction and by measuring levels of these proteins and related phospho-proteins using Western blotting.
RESULTS: Perimenopausal rats with LQS had decreased locomotor activity; reduced sucrose consumption; and increased serum levels of corticotropin releasing hormone (CRH) and corticosterone (CORT). Activation of hippocampal Raf/MEK/ERK cascade was suppressed significantly in the MCG, and activation was increased after 21 days of CSS treatment.
CONCLUSION: CSS has significant effects upon relief of the symptoms of LQS in immobilization-induced rats. The mechanism underlying this action might (at least in part) be mediated by reversal of disruption of the Raf/MEK/ERK pathway.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26427116     DOI: 10.1016/s0254-6272(15)30123-0

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  1 in total

1.  The Metabolomic Rationale for Treating Perimenopausal Syndrome as Kidney Deficiency.

Authors:  Xueqin Chen; Caiming Wu; Wen'na Liang; Jianying Shen; Zewei Zhuo; Liu Hu; Luwei Ruan; Pengheng Zhang; Leqin Xu; Chengfu Li; Shengyuan Lin; Junjie Lan; Haixia Ren; Hongwei Yao; Tongjin Zhao; Bizhen Gao; Tianwei Lin; Huiying Huang; Candong Li
Journal:  Evid Based Complement Alternat Med       Date:  2020-12-09       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.